These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 34255057)
1. AGAP2-AS1/miR-628-5p/FOXP2 feedback loop facilitates the growth of prostate cancer via activating WNT pathway. Zhao X; Liu Y; Luo C; Zuo Y Carcinogenesis; 2021 Oct; 42(10):1270-1280. PubMed ID: 34255057 [TBL] [Abstract][Full Text] [Related]
2. E2F4-induced AGAP2-AS1 up-regulation accelerates the progression of colorectal cancer via miR-182-5p/CFL1 axis. Guo Z; Liu X; Shao H Dig Liver Dis; 2022 Jul; 54(7):878-889. PubMed ID: 34838479 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/β-catenin signaling pathway. Zheng Y; Lu S; Xu Y; Zheng J Int J Biol Macromol; 2019 May; 128():521-530. PubMed ID: 30684575 [TBL] [Abstract][Full Text] [Related]
4. Long Non-coding RNA AGAP2-AS1 Silencing Inhibits PDLIM5 Expression Impeding Prostate Cancer Progression Xie P; Liu M; Chen F; Wu S; Shao T; Wang W; Xu C; Zhou H Front Genet; 2020; 11():1030. PubMed ID: 33101368 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA AGAP2-AS1 promotes proliferation and metastasis in papillary thyroid cancer by miR-628-5p/KLF12 axis. Xu C; Shao Y; Liu J; Yao X; Quan F; Zhao Q; Zhao R; Kou B; Li H; Han P; Wang X; Bai Y; Zheng Z; Zhang S J Bioenerg Biomembr; 2021 Apr; 53(2):235-245. PubMed ID: 33604734 [TBL] [Abstract][Full Text] [Related]
6. Silencing lncRNA AGAP2-AS1 Upregulates miR-195-5p to Repress Migration and Invasion of EC Cells via the Decrease of FOSL1 Expression. Shen S; Li K; Liu Y; Liu X; Liu B; Ba Y; Xing W Mol Ther Nucleic Acids; 2020 Jun; 20():331-344. PubMed ID: 32199129 [TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA AGAP2-AS1/miR-628-5p/PTN Axis Modulates Proliferation, Migration, Invasion, and Apoptosis of Glioma Cells. Yan Y; Wang Y; Liu Y; Chen T; Zhu Y; Li H; Kong F Cancer Manag Res; 2020; 12():6059-6068. PubMed ID: 32801858 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA AGAP2-AS1 accelerates cell proliferation, migration, invasion and the EMT process in colorectal cancer via regulating the miR-4,668-3p/SRSF1 axis. Li H; Guo S; Zhang M; Li L; Wang F; Song B J Gene Med; 2020 Nov; 22(11):e3250. PubMed ID: 32639657 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway. Lin Y; Jian Z; Jin H; Wei X; Zou X; Guan R; Huang J Cell Death Dis; 2020 Jan; 11(1):34. PubMed ID: 31949128 [TBL] [Abstract][Full Text] [Related]
10. LncRNA AGAP2 antisense RNA 1 stabilized by insulin-like growth factor 2 mRNA binding protein 3 promotes macrophage M2 polarization in clear cell renal cell carcinoma through regulation of the microRNA-9-5p/THBS2/PI3K-Akt pathway. Xu P; Feng DX; Wang J; Wang YD; Xie G; Zhang B; Li XH; Zeng JW; Feng JF Cancer Cell Int; 2023 Dec; 23(1):330. PubMed ID: 38110984 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer. Ma T; Chen H; Wang P; Yang N; Bao J Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162 [No Abstract] [Full Text] [Related]
12. LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4. Wu X; Xiao Y; Zhou Y; Zhou Z; Yan W Cell Death Dis; 2019 Jun; 10(7):472. PubMed ID: 31209207 [TBL] [Abstract][Full Text] [Related]
13. Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2. Yu L; Gui S; Liu Y; Qiu X; Zhang G; Zhang X; Pan J; Fan J; Qi S; Qiu B Aging (Albany NY); 2019 Aug; 11(15):5300-5318. PubMed ID: 31386624 [TBL] [Abstract][Full Text] [Related]
14. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells. Bai T; Liu Y; Li B IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543 [TBL] [Abstract][Full Text] [Related]
15. Extracellular Vesicles Long Non-Coding RNA AGAP2-AS1 Contributes to Cervical Cancer Cell Proliferation Through Regulating the miR-3064-5p/SIRT1 Axis. Li M; Wang J; Ma H; Gao L; Zhao K; Huang T Front Oncol; 2021; 11():684477. PubMed ID: 34796103 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression. Liu DC; Song LL; Liang Q; Hao L; Zhang ZG; Han CH J Cell Physiol; 2019 Aug; 234(8):12727-12744. PubMed ID: 30613973 [TBL] [Abstract][Full Text] [Related]
17. The FOXP4-AS1/miR-3130-3p/SP4 feedback loop is associated with prostate cancer. Gu T; Pan H; Zhang F; Wang L; Cheng Z Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):161-166. PubMed ID: 37114256 [TBL] [Abstract][Full Text] [Related]
18. Down-regulated lncRNA AGAP2-AS1 contributes to pre-eclampsia as a competing endogenous RNA for JDP2 by impairing trophoblastic phenotype. Xu Y; Xia X; Jiang Y; Wu D; Wang S; Fu S; Yang N; Zhang Y; Sun L J Cell Mol Med; 2020 Apr; 24(8):4557-4568. PubMed ID: 32150333 [TBL] [Abstract][Full Text] [Related]
19. LncRNA MCF2L-AS1 aggravates the malignant development of colorectal cancer via targeting miR-105-5p/RAB22A axis. Kong W; Li H; Xie L; Cui G; Gu W; Zhang H; Ma W; Zhou Y BMC Cancer; 2021 Sep; 21(1):1069. PubMed ID: 34592939 [TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway. Song X; Wang H; Wu J; Sun Y Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168 [No Abstract] [Full Text] [Related] [Next] [New Search]